mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |